Zevra Therapeutics Inc.

ZVRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.65

-$0.02 (-0.17%)

Sep 22, 2026, 1:32 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	83.23M	-105.51M	-46.05M	-26.77M	-8.56M	-12.76M
Depreciation & Amortization	4.05M	6.39M	1.01M	944K	257K	273K
Stock-Based Compensation	12.63M	14.91M	5.95M	n/a	2.44M	2.49M
Other Working Capital	2.36M	-1.04M	3.63M	3.09M	-295K	157K
Other Non-Cash Items	-78.45M	5.82M	-329K	7.52M	460K	7.25M
Deferred Income Tax	3.45M	15.37M	n/a	n/a	16.2M	435K
Change in Working Capital	-26.51M	-6.64M	5.88M	-406K	-357K	374K
Operating Cash Flow	-1.6M	-69.67M	-33.54M	-18.72M	10.44M	-1.94M
Capital Expenditures	-835K	n/a	-296K	-93K	-102K	-33K
Cash Acquisitions	n/a	n/a	-30.4M	-14.09M	n/a	n/a
Purchase of Investments	-309.99M	-41.16M	-45.81M	-23.86M	-15.42M	n/a
Sales Maturities Of Investments	328.5M	25M	59.12M	1.33M	n/a	n/a
Other Investing Acitivies	448K	-6M	n/a	n/a	n/a	n/a
Investing Cash Flow	18.13M	-22.16M	-17.39M	-36.72M	-15.52M	-33K
Debt Repayment	n/a	16.29M	25.59M	12.78M	-38.1M	2.86M
Common Stock Repurchased	n/a	n/a	-3.45M	-4.72M	-2.81M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-372K	1.3M	6.32M	-33K	104.74M	-34K
Financial Cash Flow	12.06M	82.11M	28.46M	8.35M	113.11M	2.74M
Net Cash Flow	28.62M	-9.26M	-22.42M	-46.88M	108.02M	767K
Free Cash Flow	-2.43M	-69.67M	-33.83M	-18.81M	10.34M	-1.97M
Adj. Free Cash Flow	-15.07M	-84.57M	-39.79M	-18.81M	7.9M	-4.46M
Maintenance CapEx	n/a	n/a	n/a	-93K	n/a	n/a
Growth CapEx	-835K	n/a	-296K	n/a	-102K	-33K
Owner Earnings	-1.6M	-69.67M	-33.54M	-18.81M	10.44M	-1.94M